TABLE 2.
Guideline | Dosing regimen (mg/kg; h)b |
|||
---|---|---|---|---|
Patient 1 (GA = 30 wks) |
Patient 2 (GA = 38 wks) |
|||
PNA, 2 days; wt, 1.3 kg | PNA, 15 days; wt, 1.5 kg | PNA, 2 days; wt, 3.0 kg | PNA, 15 days; wt, 3.3 kg | |
Nelson | 5; 48 | 4; 24 | 4; 24 | 4; 24 |
BNFc | 5; 36 | 5; 24 | 5; 36 | 5; 24 |
Shann | 5; 36 | 5; 24 | 5; 24 | 6; 24 |
Lexicomp | 4.5; 36 | 5; 36 | 4; 24 | 5; 24 |
Center 1 | 5; 48 | 5; 36 | 4; 24 | 4; 24 |
Center 3 | 4–5; 36 | 4–5; 24 | 4–5; 24 | 4–5; 24 |
Center 6 | 4.5; 36 | 4; 24 | 4; 24 | 4; 24 |
Center 7 | 5; 24–48 | 5; 24–48 | 5; 24–48 | 5; 24–48 |
See Table 1, footnote a, for abbreviation definitions.
Dosing regimens are expressed as follows: amount (mg/kg); interval (h). Hence, “5; 48” indicates “5 mg/kg administered every 48 h.”